Description: The Shiny web application framework by RStudio has become a popular way for data scientists working in R to create interactive data analytics. When the developer is ready to share their application with others, internally or externally, there are a number alternatives and factors to consider. This talk presents the main Shiny application hosting alternatives and considers their advantages and disadvantages. In addition, the steps necessary to deploy an application on Shiny Server, both on-prem and in the cloud using Microsoft Azure as an example, are described.

Description: What is the future of the Actuarial Profession and the Insurance Industry? Is it possible that the Actuarial Profession will become more empowered by adopting emerging technologies?

Description: This is the second half of a two-part session regarding FASB Targeted Improvement (LDTI) to U.S. GAAP for long durational insurance contracts. Presenters of the session will discuss operational (e.g., data, systems, models and process, etc.) and financial issues concerning the implementation of the accounting changes. We will also discuss interpretation of the new standards specific to accident and health insurance. Throughout the session, we would like to encourage the audience to share their experiences.

Description: Results of a company practice survey is presented. Among the areas to be addressed include the structure of accelerated underwriting programs, how programs are monitored, how accelerated underwritten business is performing relative to expectations, and how companies are considering accelerated underwriting cohorts in the context of VM-20 assumption setting.

Description: A session detailing how to calculate, understand and explain reserve movements in a PBR world. The session will illustrate how to: Calculate expected and actual reserve movements Analyze the results (SOE/GBS/EBS)Explain the results to a range of audience members, including a non-actuarial focus At the conclusion of the session, attendees will be able to evaluate reserve calculation, explain reserve movements and explain PBR earnings.

Description: Summary of research from the Initiative 18/11 - Pharmacy team about the drug development process for traditional pharmaceuticals: Who does the research and discovery? What does the research and discovery process entail? How are targets identified and validated for research and discovery? What are clinical trials and how are they conducted? How is the drug development process regulated? How is the drug development process funded?

Description: Stale portfolio got your sales down? In this session, you'll learn about the latest and greatest in product development trends and innovations which you can use to refresh and revitalize your products. At the conclusion of this session, attendees will have a better understanding on market trends in product development as well as leading innovations.

Description: Many new and innovative companies are leveraging technology to improve the effectiveness of the care provided to patients. They are employing better tools to identify patients who can benefit from specific programs that best meet the patient's need. They are also dramatically increasing the use of these programs by guiding plan members through the maze of offerings to match them with the programs that will be most beneficial to them. Employers are making these third party programs available to their members and Medicare Plans are using these new tools to identify emerging health risks for early intervention and more accurate risk scoring. This session will explore some examples of these programs, how they are being effectively integrated into the operations of health plans and how the results of these programs are being measured.The speakers will be:Raj Behal, MD, MPH,Chief Quality Officer, One Medical. Raj leads the quality and safety, value and innovation, and data science teams at One Medical. One Medical is changing the way primary care is delivered with a concierge approach with technology seamlessly woven into their offering. This includes booking appointments on line, virtual face to face care, accessible medical records and health reminders.Mylea Charval,Ph.D., CEO and Founder, Savonix. Savonix is a next generation cognitive assessment platform that brings clinical, evidence-based, and all mobile digital assessment of cognitive and emotional function. These capabilities are critical for early identification of the onset of dementia and for the proper risk assessment of seniors enrolled in Medicare Advantage Plans.Ed Cymerys, FSA, Advisor. Ed will serve as moderator. Over the last six years Ed has served as an advisor to a number of early stage technology companies looking to improve the way health benefits are being delivered.Dave Sotelo, FSA, MAAA, Actuarial Manager, Collective Health, Inc. Collective Health is an integrated solution that allows self-funded employers to administer their health plans, control costs, and take care of their people -- all in one place. They have effectively integrated more than 70 distinct third party solutions for self-funded employers and are rigorously assessing the impact of these programs

Description: Process risk, estimation error, model uncertainty, trend risk and catastrophe risk are the five main components of longevity risk uncertainty. In the face of this daunting uncertainty, what should the actuarial practitioner do? This session focuses on assessing model uncertainty, process risk and estimation error in mortality modeling. Besides discussing the theory behind methods for performing the assessment, presenters provide attendees with practical examples using R to help them in applying the methodologies and concepts presented.